4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001628280-21-015647
Options or other derivatives
- General Counsel acquired 326,526 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Murphy Matthew B. General Counsel | 2021-06-14 | Grant or award · Stock Option (Right to Buy) | +326,526 | 326,526 | D | ||
Loading xslF345X03/wf-form4_162812167372819.xml…